Matthew Rivellese

Background

About Matthew Rivellese

I am an accomplished specialty neuropsychiatry sales professional with extensive experience selling 12 disease states in Psychiatry and Neurology settings for over 20 years during which, I successfully launched 5 drugs including Strattera, Symbyax, Cymbalta, Rexulti, and Abilify Asimtufii. I have a proven track record of ranking in the top 30% or better throughout my career while also leading with roles of District Sales Trainer and Regional Sales Trainer. Disease states that I have experience with include depression, anxiety, ADHD, schizophrenia, bipolar disorder, Alzheimer's disease, pain, epilepsy, movement disorders, neuromuscular disorders, multiple sclerosis, autoimmune disorders, and neurogenetics. I strive to engage my providers and earn their trust with my credibility for better patient care outcomes. My track record to drive business results from use of superior selling competencies and my ability to articulate scientific data are also strong attributes that have made me a successful specialty pharmaceutical representative. Some highlights of my sales career include: 3 District MVP/Peer Awards 3 Turn-Around Awards 2 Time Recipient of Customer Value Metric (CVM) Award 3 Time Recipient of a Recognition Grant from Lilly for exceptional performance 2 Time National Finalist for the Exceptional Customer Experience Award Successfully launched 5 neuroscience products Top 1/3 portfolio finish 8 out of past 10 years Top 20% 5 years in a row at Otsuka